Programmed death-ligand 1 (PD-L1) is expressed on the cell surface of tumour cells as a ligand for programmed death-1 (PD-1) and inhibits T cell activation (Chen et al, 2022; Li et al, 2022). The gene discussed is CD274; the disease is neoplasm.